Anxiety disorders in Parkinson's disease

L. Marsh

Research output: Contribution to journalArticle

Abstract

Clinically significant anxiety syndromes are a common problem in PD, with prevalence rates of up to 40% of patients with Parkinson's disease (PD). Although limited attention has been paid to PD-related anxiety disorders, they contribute substantially to morbidity and caregiver burden. In some patients, the anxiety syndrome is a prevailing problem, over and above the impairment related to motor dysfunction. There is also evidence that anxiety disorders in PD are fundamentally related to underlying neurodegenerative processes. While anxiety syndromes occur in isolation, there is also overlap among anxiety symptoms and signs, PD-related depressive syndromes, PD motor phenomena, and effects of antiparkinsonian medications. Together, these factors can contribute to the misattribution of pathological anxiety as a normal psychological reaction to motor-related disability, and, hence, reduced recognition and treatment of a discrete anxiety syndrome. The primary aims of this article are to review the clinical features of the different anxiety syndromes in PD, describe the potential interplay between motor, cognitive, and affective abnormalities, and discuss the proposed mechanisms of anxiety disorders in PD and related treatment approaches.

Original languageEnglish (US)
Pages (from-to)307-318
Number of pages12
JournalInternational Review of Psychiatry
Volume12
Issue number4
StatePublished - 2000

Fingerprint

Anxiety Disorders
Parkinson Disease
Anxiety
Antiparkinson Agents
Depressive Disorder
Caregivers
Signs and Symptoms
Psychology
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Anxiety disorders in Parkinson's disease. / Marsh, L.

In: International Review of Psychiatry, Vol. 12, No. 4, 2000, p. 307-318.

Research output: Contribution to journalArticle

Marsh, L. / Anxiety disorders in Parkinson's disease. In: International Review of Psychiatry. 2000 ; Vol. 12, No. 4. pp. 307-318.
@article{668ab1c32b7d4d3db364727b2994df05,
title = "Anxiety disorders in Parkinson's disease",
abstract = "Clinically significant anxiety syndromes are a common problem in PD, with prevalence rates of up to 40{\%} of patients with Parkinson's disease (PD). Although limited attention has been paid to PD-related anxiety disorders, they contribute substantially to morbidity and caregiver burden. In some patients, the anxiety syndrome is a prevailing problem, over and above the impairment related to motor dysfunction. There is also evidence that anxiety disorders in PD are fundamentally related to underlying neurodegenerative processes. While anxiety syndromes occur in isolation, there is also overlap among anxiety symptoms and signs, PD-related depressive syndromes, PD motor phenomena, and effects of antiparkinsonian medications. Together, these factors can contribute to the misattribution of pathological anxiety as a normal psychological reaction to motor-related disability, and, hence, reduced recognition and treatment of a discrete anxiety syndrome. The primary aims of this article are to review the clinical features of the different anxiety syndromes in PD, describe the potential interplay between motor, cognitive, and affective abnormalities, and discuss the proposed mechanisms of anxiety disorders in PD and related treatment approaches.",
author = "L. Marsh",
year = "2000",
language = "English (US)",
volume = "12",
pages = "307--318",
journal = "International Review of Psychiatry",
issn = "0954-0261",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Anxiety disorders in Parkinson's disease

AU - Marsh, L.

PY - 2000

Y1 - 2000

N2 - Clinically significant anxiety syndromes are a common problem in PD, with prevalence rates of up to 40% of patients with Parkinson's disease (PD). Although limited attention has been paid to PD-related anxiety disorders, they contribute substantially to morbidity and caregiver burden. In some patients, the anxiety syndrome is a prevailing problem, over and above the impairment related to motor dysfunction. There is also evidence that anxiety disorders in PD are fundamentally related to underlying neurodegenerative processes. While anxiety syndromes occur in isolation, there is also overlap among anxiety symptoms and signs, PD-related depressive syndromes, PD motor phenomena, and effects of antiparkinsonian medications. Together, these factors can contribute to the misattribution of pathological anxiety as a normal psychological reaction to motor-related disability, and, hence, reduced recognition and treatment of a discrete anxiety syndrome. The primary aims of this article are to review the clinical features of the different anxiety syndromes in PD, describe the potential interplay between motor, cognitive, and affective abnormalities, and discuss the proposed mechanisms of anxiety disorders in PD and related treatment approaches.

AB - Clinically significant anxiety syndromes are a common problem in PD, with prevalence rates of up to 40% of patients with Parkinson's disease (PD). Although limited attention has been paid to PD-related anxiety disorders, they contribute substantially to morbidity and caregiver burden. In some patients, the anxiety syndrome is a prevailing problem, over and above the impairment related to motor dysfunction. There is also evidence that anxiety disorders in PD are fundamentally related to underlying neurodegenerative processes. While anxiety syndromes occur in isolation, there is also overlap among anxiety symptoms and signs, PD-related depressive syndromes, PD motor phenomena, and effects of antiparkinsonian medications. Together, these factors can contribute to the misattribution of pathological anxiety as a normal psychological reaction to motor-related disability, and, hence, reduced recognition and treatment of a discrete anxiety syndrome. The primary aims of this article are to review the clinical features of the different anxiety syndromes in PD, describe the potential interplay between motor, cognitive, and affective abnormalities, and discuss the proposed mechanisms of anxiety disorders in PD and related treatment approaches.

UR - http://www.scopus.com/inward/record.url?scp=0033637550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033637550&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033637550

VL - 12

SP - 307

EP - 318

JO - International Review of Psychiatry

JF - International Review of Psychiatry

SN - 0954-0261

IS - 4

ER -